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Tissue lithography will enable physi-
cians and researchers to obtain macro-
molecules with high purity (>90 per-
cent) from desired cells in
conventionally processed, clinical tissues
by simply annotating the desired cells on
a computer screen. After identifying the
desired cells, a suitable lithography mask
will be generated to protect the contents
of the desired cells while allowing de-
struction of all undesired cells by irradi-
ation with ultraviolet light. The DNA
from the protected cells can be used in a
number of downstream applications in-
cluding DNA sequencing. The purity
(i.e., macromolecules isolated form spe-
cific cell types) of such specimens will
greatly enhance the value and informa-
tion of downstream applications. 
In this method, the specific cells are
isolated on a microscope slide using pho-
tolithography, which will be faster, more
specific, and less expensive than current
methods. It relies on the fact that many
biological molecules such as DNA are
photosensitive and can be destroyed by
ultraviolet irradiation. Therefore, it is
possible to “protect” the contents of de-
sired cells, yet destroy undesired cells.
This approach leverages the technolo-
gies of the microelectronics industry,
which can make features smaller than 1
µm with photolithography. 
A variety of ways has been created to
achieve identification of the desired cell,
and also to designate the other cells for
destruction. This can be accomplished
through chrome masks, direct laser writ-
ing, and also active masking using dy-
namic arrays. Image recognition is envi-
sioned as one method for identifying
cell nuclei and cell membranes. The
pathologist can identify the cells of inter-
est using a microscopic computerized
image of the slide, and appropriate cus-
tom software. 
In one of the approaches described in
this work, the software converts the se-
lection into a digital mask that can be
fed into a direct laser writer, e.g. the
Heidelberg DWL66. Such a machine
uses a metalized glass plate (with
chrome metallization) on which there is
a thin layer of photoresist. The laser
transfers the digital mask onto the pho-
toresist by direct writing, with typical
best resolution of 2 µm. The plate is
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This method for extracting pure DNA from single cancer cells enables high-specificity cancer
identification. 
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Improved devices have been proposed
for collecting sweat for biochemical
analysis — especially for determination
of the concentration of Ca2+ ions in
sweat as a measure of loss of Ca from
bones. Unlike commercially available
sweat-collection patches used previously
in monitoring osteoporosis and in quali-
tative screening for some drugs, the pro-
posed devices would not allow evapora-
tion of the volatile chemical components
(mostly water) of sweat. Moreover, the
proposed devices would be designed to
enable determination of the volumes of
collected sweat. From these volumes and
the quantities of Ca2+ and/or other ana-
lytes as determined by other means sum-
marized below, one could determine the
concentrations of the analytes in sweat.
A device according to the proposal
would be flexible and would be worn
like a commercial sweat-collection
patch. It would be made of molded
polydimethylsiloxane (silicone rub-
ber) or other suitable material having
properties that, for the purpose of an-
alyzing sweat, are similar to those of
glass. The die for molding the silicone
rubber would be fabricated by a com-
bination of lithography and electro-
plating. The die would reproducibly
form, in the silicone rubber, a pre-
cisely defined number of capillary
channels per unit area, each channel
having a precisely defined volume. Op-
tionally, electrodes for measuring the
Ca2+ content of the sweat could be in-
corporated into the device. 
The volume of sweat collected in the
capillary channels of the device would
be determined from (1) the amount of
light or radio waves of a given wave-
length absorbed by the device and (2)
the known geometry of the array of cap-
illary channels. Then, in one of two op-
tions, centrifugation would be per-
formed to move the sweat from the
capillary tubes to the region containing
the electrodes, which would be used to
measure the Ca2+ content by a standard
technique. In the other option, centrifu-
gation would be performed to remove
the sweat from the device to make the
sweat available to other analytical instru-
ments for measuring concentrations of
substances other than Ca2+.
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Unlike prior devices, these would enable measurement of volumes of specimens.
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then developed to remove the exposed
photoresist, which leaves the exposed
areas susceptible to chemical chrome
etch. The etch removes the unprotected
chrome. The rest of the photoresist is
then removed, by either ultraviolet or-
ganic solvent or overdevelopment. The
remaining chrome pattern is quickly ox-
idized by atmospheric exposure (typi-
cally within 30 seconds). 
The ready chrome mask is now applied
to the tissue slide and aligned manually, or
using automatic software and pre-de-
signed alignment marks. The slide plate
sandwich is then exposed to UV to destroy
the DNA of the unwanted cells. The slide
and plate are separated and the slide is
processed in a standard way to prepare for
polymerase chain reaction (PCR) and po-
tential identification of cancer sequences. 
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This invention relates to surface modi-
fication of porosified silicon (pSi) struc-
tures with poly(alkylene) glycols for the
purpose of controlled degradation of the
silicon matrix and tailored release of en-
capsulated substances for biomedical ap-
plications. The pSi structures are cur-
rently used in diverse biomedical
applications including bio-molecular
screening, optical bio-sensoring, and
drug delivery by means of injectable/
orally administered carriers and im-
plantable devices. 
The size of the pores and the surface
chemistry of the pSi structure can be con-
trolled during the microfabrication process
and thereafter. A fine regulation of the
degradation kinetics of mesoporous silicon
structures is of fundamental importance.
Polyethylene glycols (PEGs) represent the
major category of surface modifying agents
used in classical drug delivery systems and
in pharmaceutical dosage forms. PEGyla-
tion enables avoidance of RES uptake, thus
prolonging circulation time of intra-
venously injectable nanovectors. PEG mole-
cules demonstrate little toxicity and im-
munogenicity, and are cleared from the
body through the urine (molecular weight,
MW<30 kDa) or in the feces (MW>30kDa). 
The invention focuses on the possibility
of finely tuning the degradation kinetics
of the pSi nanovectors and other struc-
tures through surface conjugation of
PEGs with various backbone lengths/
MWs. To prove the concept, pSi nanovec-
tors were covalently conjugated to seven
PEGs with MW from 245 to 5,000 Da and
their degradation kinetics in physiologi-
cally relevant media (phosphate buffer
saline, PBS pH7.4, and fetal bovine
serum) was assessed by the elemental
analysis of the Si using inductive coupled
plasma atomic emission spectroscopy
(ICP-AES). The conjugation of the PEG
with lowest MW to the nanovectors surface
did not induce any change in the degrada-
tion kinetics in serum, but inhibited
degradation and consequently the release
of orthosilicic acid into buffer. When PEGs
with the longer chains were evaluated, Si
mass loss from the nanovectors was slowed
down, and the PEGylated structures were
almost fully degraded within 18–24 hours
in serum and within 48 hours in PBS. The
most dramatic effect was observed for
high MW PEGs 3,400 and 5,000 Da, which
prominently inhibited the degradation of
the systems, with complete degradation
achieved only after four days. For these
PEGs, during the early stages of the degra-
dation, there was a “lag” period of little or
no Si mass loss from the nanovector. 
The obtained profiles were in agree-
ment with the erosion of the nanovector
surface as observed by scanning electron
microscopy.
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Method for Impeding Degradation of Porous Silicon Structures
This method tailors degradation of a drug delivery system to enable controlled release of
therapeutic agents.
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Although suited astronauts are cur-
rently cooled with a Liquid Cooled Ven-
tilation Garment (LCVG), which can re-
move up to 85 percent of body heat,
their effectiveness is limited because
cooling must penetrate layers of skin,
muscle, fat, bone, and tissue to reach the
bloodstream, where its effect is promi-
nent. Vasoconstriction further reduces
the effectiveness by limiting arterial flow
when exposed to cold (the frostbite re-
sponse), resulting in a time constant on
External Cooling Coupled to Reduced Extremity Pressure Device 
The use of reduced-pressure boots and gloves may mitigate the effects of stroke and heart attacks.
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